Kronos Bio, Inc. - Common Stock (KRON)

CUSIP: 50107A104

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock
Total 13F shares
36,074,689
Share change
-851,452
Total reported value
$120,851,708
Price per share
$3.35
Number of holders
90
Value change
-$3,060,166
Number of buys
31
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 50107A104?
CUSIP 50107A104 identifies KRON - Kronos Bio, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q3 2022

As of 30 Sep 2022, Kronos Bio, Inc. - Common Stock (KRON) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,074,689 shares. The largest 10 holders included Omega Fund Management, LLC, BlackRock Inc., Vida Ventures Advisors, LLC, JPMORGAN CHASE & CO, PERCEPTIVE ADVISORS LLC, Artal Group S.A., BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, and Nextech Invest AG. This page lists 90 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.